Global Industrial Filtration Market Size To Exceed USD 56.2 Billion By 2033 | CAGR Of 4.79%
June 03, 2024 07:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 03, 2024 (GLOBE NEWSWIRE) -- The Global Industrial Filtration Market Size is to Grow from USD 35.2 Billion in 2023 to USD 56.2 Billion by 2033, at a Compound Annual...
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
June 03, 2024 07:00 ET
|
ATHA Energy Corp.
HIGHLIGHTS: Angilak Project: The Angilak Project is host to the Lac 50 Uranium Deposit, which is one of the largest high-grade deposits outside of the Athabasca Basin, with a...
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
June 03, 2024 07:00 ET
|
Beyond Air™
– Ongoing Phase 1a first-in-human clinical trial continues to demonstrate proof of concept for the UNO solid tumor platform with observed early tumor responses and clinical resolution of radiation...
Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
June 03, 2024 07:00 ET
|
Stallion Uranium Corp.
Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
Canoo Announces Participation in June Investor Conferences
June 03, 2024 07:00 ET
|
Canoo, Inc.
Canoo will participate in the upcoming Stifel Cross Sector Insight and Sidoti Small Cap investor conferences.
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024 07:00 ET
|
Century Therapeutics, Inc.
In ongoing dose escalation, CNTY-101 has demonstrated a manageable safety profile with no observed DLTs or GvHD and with majority of patients treated in outpatient setting Encouraging preliminary...
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
June 03, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 03, 2024 07:00 ET
|
Entrada Therapeutics, Inc.
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new...
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
June 03, 2024 07:00 ET
|
Aruna Bio
BOSTON and ATHENS, Ga., June 03, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced the...
Alpine Income Property Trust Announces Sale of a Senior Portion of First Mortgage Loan Investment
June 03, 2024 06:59 ET
|
Alpine Income Property Trust
WINTER PARK, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) announced today that it has sold a $13.6 million A-1 participation...